Eroglu Z, Kim Y, Gibney G, et al. Mature results of combination nivolumab (NIVO) plus ipilimumab (IPI) as adjuvant therapy in stage IIIC/IV melanoma (MEL). SMR 2017, abstract SMR09-06.
NIVO3+IPI1 versus NIVO1+IPI3 bij gevorderd melanoom: CheckMate 511
apr 2019 | Dermato-oncologie, Immuuntherapie